Their following study, which used whole exome sequencing and whole transcriptome sequencing on 29 ESCC patients with paired before and after CCRT samples, showed that both tumor mutation burden and neoantigen load reduced, and the PD-L1 protein expression had no definitive change [26]. The gene discussed is CD274; the disease is neoplasm.